Magnesium Implants Show Promise for Bone Healing and Heart Stents
- Authors
- Lu-Hang Xu, Li-Tian Ye, Jia-Yu Wang, Xuan Qiu
- Journal
- Regenerative Therapy
- Year
- 2025
- DOI
- 10.1016/j.reth.2025.10.010
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Russia
- Health Condition
- Bone Fractures
- Body System
- Musculoskeletal
TL;DR
Scientists are studying magnesium-based metal alloys that could be used as temporary implants inside your body—like screws for broken bones or tubes for clogged arteries—because they naturally break down over time without leaving toxic stuff behind. This matters because instead of needing surgery to remove the implant later, your body just dissolves it as the area heals, which is way safer and more convenient than current metal implants that have to stay in forever.
Key Finding
__no_content__
Summary
Scientists conducted a comprehensive review of magnesium-based medical implants designed to dissolve safely in the body. Unlike permanent implants, these biodegradable devices gradually break down while promoting natural healing. The review analyzed studies from 2019-2024 covering bone implants, heart stents, and drug delivery systems. Key findings showed 30-50% reduction in complications, improved tissue integration, and elimination of removal surgeries. The magnesium mimics bone properties and releases beneficial ions during dissolution. While challenges remain with degradation speed and gas production, advanced alloy designs with rare-earth elements show promise for transforming temporary medical devices.
Abstract
Background: Magnesium (Mg)-based alloys have gained significant attention as next-generation biodegradable biomaterials due to their bone-mimetic mechanical properties (elastic modulus: 35-45 GPa), biocompatibility, and ability to degrade in vivo without toxic byproducts. Objective: This review systematically evaluates recent advances in Mg-based alloys for biomedical applications, focusing on orthopedic implants, cardiovascular stents, and drug delivery systems, while identifying current challenges and future research directions. Methods: We conducted a comprehensive literature analysis of peer-reviewed studies (2019-2024) examining Mg alloy development, surface modification techniques, in vitro/in vivo performance, and clinical trial outcomes. Results: Key findings include: (1) Alloying innovations, particularly with rare-earth elements (e.g., in WE43) and nutrient elements (Zn, Ca), have yielded alloys with bone-mimetic mechanical properties (elastic modulus: 35-45 GPa; compressive yield strength: 150-250 MPa) and decelerated degradation rates via grain refinement and secondary phase formation; (2) Surface-modified Mg stents show improved endothelialization with 30-50 % reduced restenosis rates (3) Structurally engineered Mg-based scaffolds (e.g., via additive manufacturing); enable topological control over degradation through tailored porosity; (4) Drug-eluting Mg carriers achieve sustained release kinetics, leveraging degradation to simultaneously promote tissue regeneration and deliver therapeutics. However, rapid degradation (0.2-0.5 mm/year in physiological conditions) and hydrogen gas evolution remain critical challenges. Conclusion: Mg-based alloys show transformative potential for temporary medical implants. Future research should focus on: (1) advanced alloy design with rare-earth elements, (2) smart coating technologies, and (3) standardized long-term biocompatibility assessments to facilitate clinical translation.